Mar 6, 2023 | Access solutions, Cost Savings, MedBen Rx, Medicare, Research, Rx Costs, Savings, Specialty Drugs
Employers pay up to 30 times as much for specialty drugs than Medicare does, new research finds. According to the JAMA Health Forum, for the 10 most commonly used specialty drugs, employer-sponsored insurance (ESI) plans paid prices up to 3,350% higher than Medicare....
Feb 6, 2023 | Announcements, Benchmarks, Case Studies, Compliance, Direct-to-Employer Contracting, MedBen Rx, MedBen University, Roundtables, Rx Costs, Specialty Drugs, Supreme Court
The 22nd Season of MedBen University (MBU) will soon be in session! In 2023, MBU will explore current benefit management issues and proven solutions MedBen offers, including: Reducing Rx spend through alternative specialty drug funding, as well as other pharmacy plan...
Feb 3, 2023 | Alternative Reimbursement Strategies, Claims, Cost Savings, Direct-to-Employer Contracting, Drug costs, Forensic claims review, Gene therapy, Health care costs, Inflation, MedBen Rx, MedBen WellLiving, Prescription, Rx Costs, Savings, Specialty Drugs, Wellness
Even though health care costs have not seen the same rate of inflation as other industries, that’s about to change. Fortunately, MedBen has a variety of inflation-hedging solutions to counter rising costs. As a recent Self-Insurer article notes, health care...
Feb 1, 2023 | Legislative, MedBen Rx, Pharmacy Benefits Manager (PBM), Rx Costs
Pharmacy benefits managers (PBMs) are increasingly being called to answer for their questionable business practices at multiple levels of government. On the state level, in recent months: A major PBM has settled with Iowa and at least 14 other states for overbilling...
Jan 23, 2023 | Avande, Cost Savings, Drug costs, Gene therapy, Luke Burchard, MedBen Rx, Rx Costs, Savings
In two recent articles, we touched on the growing prevalence of high-cost drugs, some with price tags in the thousands and even millions of dollars: Drugmakers are raising prices on over 350 unique drugs this month.Innovative gene therapies have emerged that cost as...
Jan 6, 2023 | Drug costs, Drugmakers, News, Prescription, Rx Costs
From Reuters: “Drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA plan to raise prices in the United States on more than 350 unique drugs in early January, according to data analyzed by healthcare research...
